title: Electroconvulsive therapy in neuroleptic-induced parkinsonism.
abstract: The effect of electroconvulsive therapy (ECT) on the severity of neuroleptic-induced parkinsonism was studied in nine schizophrenic inpatients in a longitudinal triphasic design: neuroleptics-neuroleptics plus ECT-neuroleptics. The results suggest that ECT has a true antiparkinsonian potential. The role of ECT in the treatment of Parkinson's disease, especially with therapy-resistant patients complicated with on-off symptoms, is highlighted.
authors.affiliation: Department of Psychiatry, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER) Pondicherry, India.
authors.forename: U
authors.initials: U
authors.lastname: Goswami
authors.forename: S
authors.initials: S
authors.lastname: Dutta
authors.forename: K
authors.initials: K
authors.lastname: Kuruvilla
authors.forename: E
authors.initials: E
authors.lastname: Papp
authors.forename: A
authors.initials: A
authors.lastname: Perenyi
mesh_terms: D000293:Adolescent; D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002746:Chlorpromazine / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D004565:Electroconvulsive Therapy; D005260:Female; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D010302:Parkinson Disease, Secondary / Q000139:chemically induced* / Q000628:therapy; D010865:Pilot Projects; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000188:drug therapy*; D012565:Schizophrenic Psychology
chemical_list: D014150:Antipsychotic Agents; D002746:Chlorpromazine